Normal dystrophin transcripts detected in Duchenne muscular dystrophy patients after myoblast transplantation. 1992

E Gussoni, and G K Pavlath, and A M Lanctot, and K R Sharma, and R G Miller, and L Steinman, and H M Blau
Department of Neurology and Neurological Sciences, Stanford University School of Medicine, California 94305.

Gene delivery by transplantation of normal myoblasts has been proposed as a treatment of the primary defect, lack of the muscle protein dystrophin, that causes Duchenne muscular dystrophy (DMD), a lethal human muscle degenerative disorder. To test this possibility, we transplanted normal myoblasts from a father or an unaffected sibling into the muscle of eight boys with DMD, and assessed their production of dystrophin. Three patients with deletions in the dystrophin gene expressed normal dystrophin transcripts in muscle biopsy specimens taken from the transplant site one month after myoblast injection. Using the polymerase chain reaction we established that the dystrophin in these biopsies derived from donor myoblast DNA. These results show that transplanted myoblasts persist and produce dystrophin in muscle fibres of DMD patients.

UI MeSH Term Description Entries
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009132 Muscles Contractile tissue that produces movement in animals. Muscle Tissue,Muscle,Muscle Tissues,Tissue, Muscle,Tissues, Muscle
D009136 Muscular Dystrophies A heterogeneous group of inherited MYOPATHIES, characterized by wasting and weakness of the SKELETAL MUSCLE. They are categorized by the sites of MUSCLE WEAKNESS; AGE OF ONSET; and INHERITANCE PATTERNS. Muscular Dystrophy,Myodystrophica,Myodystrophy,Dystrophies, Muscular,Dystrophy, Muscular,Myodystrophicas,Myodystrophies
D009838 Oligodeoxyribonucleotides A group of deoxyribonucleotides (up to 12) in which the phosphate residues of each deoxyribonucleotide act as bridges in forming diester linkages between the deoxyribose moieties. Oligodeoxynucleotide,Oligodeoxyribonucleotide,Oligodeoxynucleotides
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D005091 Exons The parts of a transcript of a split GENE remaining after the INTRONS are removed. They are spliced together to become a MESSENGER RNA or other functional RNA. Mini-Exon,Exon,Mini Exon,Mini-Exons
D006650 Histocompatibility Testing Identification of the major histocompatibility antigens of transplant DONORS and potential recipients, usually by serological tests. Donor and recipient pairs should be of identical ABO blood group, and in addition should be matched as closely as possible for HISTOCOMPATIBILITY ANTIGENS in order to minimize the likelihood of allograft rejection. (King, Dictionary of Genetics, 4th ed) Crossmatching, Tissue,HLA Typing,Tissue Typing,Crossmatchings, Tissue,HLA Typings,Histocompatibility Testings,Testing, Histocompatibility,Testings, Histocompatibility,Tissue Crossmatching,Tissue Crossmatchings,Tissue Typings,Typing, HLA,Typing, Tissue,Typings, HLA,Typings, Tissue
D006680 HLA Antigens Antigens determined by leukocyte loci found on chromosome 6, the major histocompatibility loci in humans. They are polypeptides or glycoproteins found on most nucleated cells and platelets, determine tissue types for transplantation, and are associated with certain diseases. Human Leukocyte Antigen,Human Leukocyte Antigens,Leukocyte Antigens,HL-A Antigens,Antigen, Human Leukocyte,Antigens, HL-A,Antigens, HLA,Antigens, Human Leukocyte,Antigens, Leukocyte,HL A Antigens,Leukocyte Antigen, Human,Leukocyte Antigens, Human
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

E Gussoni, and G K Pavlath, and A M Lanctot, and K R Sharma, and R G Miller, and L Steinman, and H M Blau
August 2001, Genetika,
E Gussoni, and G K Pavlath, and A M Lanctot, and K R Sharma, and R G Miller, and L Steinman, and H M Blau
July 1990, Lancet (London, England),
E Gussoni, and G K Pavlath, and A M Lanctot, and K R Sharma, and R G Miller, and L Steinman, and H M Blau
June 2010, Muscle & nerve,
E Gussoni, and G K Pavlath, and A M Lanctot, and K R Sharma, and R G Miller, and L Steinman, and H M Blau
July 1993, Annals of neurology,
E Gussoni, and G K Pavlath, and A M Lanctot, and K R Sharma, and R G Miller, and L Steinman, and H M Blau
August 1991, Clinical science (London, England : 1979),
E Gussoni, and G K Pavlath, and A M Lanctot, and K R Sharma, and R G Miller, and L Steinman, and H M Blau
November 1989, Seikagaku. The Journal of Japanese Biochemical Society,
E Gussoni, and G K Pavlath, and A M Lanctot, and K R Sharma, and R G Miller, and L Steinman, and H M Blau
October 2009, Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery,
E Gussoni, and G K Pavlath, and A M Lanctot, and K R Sharma, and R G Miller, and L Steinman, and H M Blau
July 2009, Molecular therapy : the journal of the American Society of Gene Therapy,
E Gussoni, and G K Pavlath, and A M Lanctot, and K R Sharma, and R G Miller, and L Steinman, and H M Blau
January 1989, Neuron,
E Gussoni, and G K Pavlath, and A M Lanctot, and K R Sharma, and R G Miller, and L Steinman, and H M Blau
January 1993, Neuromuscular disorders : NMD,
Copied contents to your clipboard!